PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 18509013-8 2008 MPO concentrations were consistently higher in samples collected in serum and heparin plasma tubes than in samples in EDTA or citrate tubes. Citric Acid 126-133 myeloperoxidase Homo sapiens 0-3 9249774-9 1997 Citrate abolished the release of MPO almost completely, whereas LF release was partially inhibited. Citric Acid 0-7 myeloperoxidase Homo sapiens 33-36 8395934-1 1993 When phenylalanine was incubated with myeloperoxidase (MPO) and NADH in citrate buffer (pH 4.5), o-, m-, and p-tyrosines were identified as hydroxylated products. Citric Acid 72-79 myeloperoxidase Homo sapiens 38-53 22107692-2 2011 This is the first study conducted to examine the potentially additive benefit effect of regional citrate anticoagulation (RCA) on polymorphonuclear (PMN) cell degranulation of myeloperoxidase (MPO) and cytokines production in patients with critically acute kidney injury (AKI) undergoing CVVH treatment. Citric Acid 97-104 myeloperoxidase Homo sapiens 176-191 22107692-2 2011 This is the first study conducted to examine the potentially additive benefit effect of regional citrate anticoagulation (RCA) on polymorphonuclear (PMN) cell degranulation of myeloperoxidase (MPO) and cytokines production in patients with critically acute kidney injury (AKI) undergoing CVVH treatment. Citric Acid 97-104 myeloperoxidase Homo sapiens 193-196 22107692-8 2011 Citrate could significantly decrease systemic pre-filter serum MPO levels from baseline at 6 h (median 43.5 vs. 17.3 ng/mL, P<0.01) as well as IL-8 levels (P<0.05) whereas heparin provided only significant TNF-alpha reduction (P<0.05). Citric Acid 0-7 myeloperoxidase Homo sapiens 63-66